WASHINGTON — A Food and Drug Administration advisory panel recommended on Friday that compounding pharmacies be allowed to ...

The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of research ...

Today, a win for RFK Jr., as an FDA panel narrowly voted in favor of allowing compounding pharmacies to produce certain ...

Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started ...

The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes ...

Federal health officials are investigating a new outbreak of the diarrhea-causing parasite. We don’t know where or which ...

The White House and the Department of Health and Human Services will convene experts to discuss the benchmarking and ...

A study of Lilly's retatrutide weight loss drug in people with heart disease did not answer a crucial question — whether it ...

Timothy Westlake, an emergency doctor nominated to head SAMHSA, has been active in addiction policy in Wisconsin.

A study of the long-term health impact of the Lahaina wildfires is inspiring a new model for disaster recovery and support.

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Mirroring the bipartisan bill introduced in the House, the measure would require a study from the GAO on the state of men’s ...